C-di-AMP sensitizes colorectal cancer to CD47 antibodies by activating NF-κB to promote macrophage phagocytosis.
1/5 보강
[OBJECTIVE] Developing effective therapeutic strategies for colorectal cancer (CRC) presents a significant clinical challenge.
APA
Hao Y, Fan Y, et al. (2026). C-di-AMP sensitizes colorectal cancer to CD47 antibodies by activating NF-κB to promote macrophage phagocytosis.. Cell communication and signaling : CCS, 24(1). https://doi.org/10.1186/s12964-026-02703-8
MLA
Hao Y, et al.. "C-di-AMP sensitizes colorectal cancer to CD47 antibodies by activating NF-κB to promote macrophage phagocytosis.." Cell communication and signaling : CCS, vol. 24, no. 1, 2026.
PMID
41620598
Abstract
[OBJECTIVE] Developing effective therapeutic strategies for colorectal cancer (CRC) presents a significant clinical challenge. Although immune checkpoint blockade therapies, such as the CD47 blockade, have shown promise, their efficacy is often limited by suboptimal responses and associated toxicities. This study explores the potential of the gut microbial metabolite cyclic diadenosine monophosphate (c-di-AMP) to enhance the therapeutic efficacy of CD47 antibodies in treating CRC while mitigating its adverse effects.
[METHODS] A subcutaneous tumor model was established to assess the therapeutic efficacy of c-di-AMP in combination with CD47 blockade for CRC treatment. Growth inhibition assays were performed to evaluate the direct effects of c-di-AMP on CRC cells. Cell removal assays, flow cytometry, and immunofluorescence were employed to investigate the impact of c-di-AMP on macrophage-mediated phagocytosis. Macrophage polarization phenotypes were characterized by flow cytometry and immunohistochemistry. Transcriptome sequencing was also conducted to elucidate the molecular mechanisms underlying the c-di-AMP-induced enhancement of macrophage phagocytic activity.
[RESULTS] Our results revealed that c-di-AMP, in combination with CD47 blockade, exerted potent anticancer effects in vivo. Mechanistically, c-di-AMP enhanced macrophage-mediated phagocytosis triggered by CD47 blockade by promoting M1 polarization and activating the NF-κB signaling pathway. Furthermore, c-di-AMP upregulated the expression of CD11b/CD18, thereby strengthening intercellular adhesion between macrophages and CRC cells, which further facilitated phagocytosis.
[CONCLUSION] These findings indicate that c-di-AMP may enhance the efficacy of CD47 blockade in CRC by promoting macrophage phagocytosis through NF-κB activation.
[SUPPLEMENTARY INFORMATION] The online version contains supplementary material available at 10.1186/s12964-026-02703-8.
[METHODS] A subcutaneous tumor model was established to assess the therapeutic efficacy of c-di-AMP in combination with CD47 blockade for CRC treatment. Growth inhibition assays were performed to evaluate the direct effects of c-di-AMP on CRC cells. Cell removal assays, flow cytometry, and immunofluorescence were employed to investigate the impact of c-di-AMP on macrophage-mediated phagocytosis. Macrophage polarization phenotypes were characterized by flow cytometry and immunohistochemistry. Transcriptome sequencing was also conducted to elucidate the molecular mechanisms underlying the c-di-AMP-induced enhancement of macrophage phagocytic activity.
[RESULTS] Our results revealed that c-di-AMP, in combination with CD47 blockade, exerted potent anticancer effects in vivo. Mechanistically, c-di-AMP enhanced macrophage-mediated phagocytosis triggered by CD47 blockade by promoting M1 polarization and activating the NF-κB signaling pathway. Furthermore, c-di-AMP upregulated the expression of CD11b/CD18, thereby strengthening intercellular adhesion between macrophages and CRC cells, which further facilitated phagocytosis.
[CONCLUSION] These findings indicate that c-di-AMP may enhance the efficacy of CD47 blockade in CRC by promoting macrophage phagocytosis through NF-κB activation.
[SUPPLEMENTARY INFORMATION] The online version contains supplementary material available at 10.1186/s12964-026-02703-8.
같은 제1저자의 인용 많은 논문 (5)
- The early diagnostic value of lung cancer autoantibodies and tumor markers in lung cancer.
- Expression of the Necroptosis-Related Gene MLKL Correlated with Small Cell Lung Cancer Prognosis and the Immune Checkpoint.
- Genetic evidence for potential molecular mediators underlying the causal relationship between obesity and breast cancer: a two-step, two-sample Mendelian randomization study.
- The oncogenic role of ecotropic viral integration site 1 in hematological malignancies: mechanisms of activation and leukemogenesis.
- Causes of death after surgery among cancer patients: a population-based cohort study.